Category: Life Sciences
Global Life Sciences
-
Cannula
... 6.1% over the analysis period 2024-2030. Cardiac Cannula, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$135.3 Million by the end of the analysis period. Growth ... Read More
-
Automotive Carbon Thermoplastic
... at a CAGR of 23.9% over the analysis period 2024-2030. Polyamide (PA), one of the segments analyzed in the report, is expected to record a 25.9% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Bioinformatics
... 13.8% over the analysis period 2024-2030. Knowledge Management Tools, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$18.8 Billion by the end of the analysis period. ... Read More
-
Poultry Chicken
... Tons by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. The U.S. Market is Estimated at 28.8 Thousand Metric Tons While China is Forecast to Grow at 4.7% CAGR The Poultry ... Read More
-
Anticoagulants
... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More
-
Insulin Pumps
... CAGR of 7.0% over the analysis period 2024-2030. Tethered Pumps, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$15.0 Billion by the end of the analysis ... Read More
-
Alopecia Drugs
... CAGR of 5.5% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Bio-MEMS Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis ... Read More
-
Carbohydrase
... 5.6% over the analysis period 2024-2030. Amylases, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in ... Read More
-
Electronic Health Records (EHR)
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Acute EHR, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$26.3 Billion by the ... Read More
-
Endoscopic Mucosal Resection Technology
... 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Lift-and-Cut Technique, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.0 Billion by the ... Read More
-
Isothermal Nucleic Acid Amplification Technology (INAAT)
... reach US$6.7 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$4.6 ... Read More
-
Laboratory and Handheld Raman Instruments
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Laboratory Raman Instruments (LRI), one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach ... Read More
-
Aseptic Sampling
... CAGR of 10.1% over the analysis period 2024-2030. Manual Aseptic Sampling, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$357.4 Million by the end of the ... Read More
-
Automotive Pumps
... CAGR of 3.1% over the analysis period 2024-2030. Fuel Injection Pumps, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$26.9 Billion by the end of the ... Read More
-
Cardiopulmonary Autotransfusion Systems
... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More
-
Ceramic Substrates
... CAGR of 4.8% over the analysis period 2024-2030. Alumina Substrates, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$4.0 Billion by the end of the analysis ... Read More
-
Human Vaccines
... CAGR of 7.3% over the analysis period 2024-2030. Intramuscular & Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$58.7 Billion by the end of ... Read More
-
Cardiac Rehabilitation Devices
... at a CAGR of 4.8% over the analysis period 2024-2030. Treadmill, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
X-Ray Photoelectron Spectroscopy
... at a CAGR of 4.8% over the analysis period 2024-2030. Healthcare, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by the end of the ... Read More
-
Attapulgite
... 6.9% over the analysis period 2024-2030. Colloidal grade, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$320.0 Million by the end of the analysis period. Growth ... Read More
-
Automotive Electric Drive Axle
... 2030, growing at a CAGR of 32.2% over the analysis period 2024-2030. Electric Axle, one of the segments analyzed in the report, is expected to record a 28.4% CAGR and reach US$8.8 Billion by the ... Read More
-
Automotive Starter Motor and Alternator
... Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Electric, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$45.6 Billion by ... Read More
-
Biological Drugs
... CAGR of 9.1% over the analysis period 2024-2030. Therapeutic Protein, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$289.1 Billion by the end of the analysis ... Read More
-
Diagnostic Specialty Enzymes
... at a CAGR of 6.2% over the analysis period 2024-2030. Polymerases & Nucleases, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$726.2 Million by the end ... Read More
Research Assistance
